title: Can pharmacogenomics guide effective anticancer therapy in pancreatic ductal adenocarcinoma?
authors: Jonathan
authors: J
authors: Krell
authors: Adam E
authors: AE
authors: Frampton
authors: Long R
authors: LR
authors: Jiao
authors: Justin
authors: J
authors: Stebbing
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000235:genetics; D021441:Carcinoma, Pancreatic Ductal / Q000188:drug therapy* / Q000235:genetics; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000235:genetics / Q000627:therapeutic use; D033721:Equilibrative Nucleoside Transporter 1 / Q000235:genetics / Q000378:metabolism; D006801:Humans; D010597:Pharmacogenetics; D000093542:Gemcitabine
chemical_list: D033721:Equilibrative Nucleoside Transporter 1; C438649:SLC29A1 protein, human; D003841:Deoxycytidine; D000093542:Gemcitabine